<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35801751</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>27</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Association of TLR3 gene 1377C/T (rs3775290) and TLR7 gene C/G (rs3853839) polymorphism with hand, foot, and mouth disease caused by human enterovirus 71 infection susceptibility and severity in the Chinese Han population: A meta-analysis of case-control studies.</ArticleTitle><Pagination><StartPage>e29758</StartPage><MedlinePgn>e29758</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e29758</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000029758</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several case-control studies have been conducted on the relationship between rs3775290 C/T and rs3853839 C/G single nucleotide polymorphisms of the Toll-like receptor (TLR) gene and hand, foot, and mouth disease (HFMD) susceptibility and severity. This meta-analysis aimed to offer a systemic review of HFMD susceptibility and severity among the Chinese Han population associated with the C/T (rs3775290) polymorphism of the TLR3 gene or C/G (rs3853839) polymorphism of the TLR7 gene.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A computer search was conducted using PubMed, Web of Science, Embase, CNKI, CBM, VIP, and WanFang databases. The time ranges were from database establishment to 30/7/2021. Articles selected according to the inclusion and exclusion criteria underwent data extraction and methodological quality evaluation. RevMan 5.4 and Stata 16.0 were adopted for meta-analysis, and the incorporated odds ratio (OR) values and 95% confidence intervals (CIs) were calculated. Sensitivity and publication bias assessments were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">8 articles with 9 studies were selected. Among them, there were 858 cases and 577 controls in TLR3 rs3775290 studies as well as 2151 cases and 1554 controls in TLR7 rs3853839 studies. Regarding rs3775290 of TLR3, susceptibilities of the severe type of T-possessing individuals were larger than those of C-possessing individuals [OR = 1.34, 95%CI (1.10, 1.64), P = .004]. The susceptibility of individuals with the severe TT genotype was 1.61 times that of individuals with the CC genotype [95%CI (1.07, 2.43), P=0.02], while susceptibility to HFMD was not influenced by the genotype. In terms of the rs3853839 of the TLR7 gene, C allele carriers have a higher risk of developing HFMD than G allele carriers. The susceptibility to HFMD in CC+CG individuals was 1.24 times than that in GG individuals [95%CI (1.07, 1.43), P = .004]. However, no relationship was found between this polymorphism and severity of the severe type. No significant publication bias was observed in this study.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">rs3775290 (C/T) of TLR3 is associated with susceptibility to the severe type, whereas rs3853839 (C/G) of TLR7 is associated with susceptibility to HFMD. However, owing to the limited quantity and quality of the research, the aforementioned conclusions are yet to be justified by more high-quality research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Haokun</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 461 Bayi Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Weikai</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 461 Bayi Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wen</LastName><ForeName>Lequan</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9119-2022</Identifier><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 461 Bayi Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Lirui</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 461 Bayi Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xinyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 461 Bayi Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Tiangang</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 1299 Xuefu Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Changsen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Joint program of Nanchang University and Queen Mary University of London, Nanchang University, 1299 Xuefu Avenue, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495344">TLR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495348">TLR7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051199">Toll-Like Receptor 7</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="Y">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051199" MajorTopicYN="Y">Toll-Like Receptor 7</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors state no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>8</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35801751</ArticleId><ArticleId IdType="pmc">PMC9259132</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000029758</ArticleId><ArticleId IdType="pii">00005792-202207080-00022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Li X-W, Ni X, Qian S-Y, et al. . Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;14:437&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">30280313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Li J. Advances in epidemiology and etiology of hand, foot and mouth disease. Zhongguo Wei Sheng Shi Ye Guan Li. 2010;27:419&#x2013;21.</Citation></Reference><Reference><Citation>Xu C, Zhang X, Wang L, et al. . Effects of temperature fluctuations on spatial-temporal transmission of hand, foot, and mouth disease. Sci Rep. 2020;10:2541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7018740</ArticleId><ArticleId IdType="pubmed">32054890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan Z, Li J, Meng F, et al. . Epidemiological characteristics of enterovirus type 71 diseases. Zhonghua Liu Xing Bing Xue Za Zhi. 2015;36:45&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25876864</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P-C, Chen S-C, Chen K-T. The current status of the disease caused by enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health. 2016;13:890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5036723</ArticleId><ArticleId IdType="pubmed">27618078</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. . Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L-Y, Huang L-M, Gau SS-F, et al. . Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007;356:1226&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BR. Structure of fish toll-like receptors (TLR) and NOD-like receptors (NLR). Int J Biol Macromol. 2020;161:1602&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396143</ArticleId><ArticleId IdType="pubmed">32755705</ArticleId></ArticleIdList></Reference><Reference><Citation>Colonna M. TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol. 2007;37:306&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17273997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao J, Li P, Tian Y, et al. . Crosstalk between toll-like receptor 3 and Notch signaling contributes to CD14 monocytes activity in enterovirus 71 infected hand, foot, and mouth disease. Int Immunopharmacol. 2018;60:26&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29702280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Suo X, Zhang Y. Association of IL-13, S100B, and TLR-7 gene polymorphisms with enterovirus 71 infection in hand, foot, and mouth disease in China. Genet Test Mol Biomarkers. 2019;23:188&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">30807256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Shang H, Cao X, et al. . Association of polymorphisms in TLR2 and TLR4 with asthma risk: an update meta-analysis. Medicine (Baltim). 2017;96:e7909.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585505</ArticleId><ArticleId IdType="pubmed">28858111</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdeli A, Celik HA, Ozy&#xfc;rek R, et al. . TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med (Berl). 2005;83:535&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">15968536</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W, Kim TH, Oh SJ, et al. . Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-&#x3b1; inhibitors and development of machine learning models. Sci Rep. 2021;11:20169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505487</ArticleId><ArticleId IdType="pubmed">34635730</ArticleId></ArticleIdList></Reference><Reference><Citation>Akta&#x15f; T, Celik SK, Genc GC, et al. . Higher levels of serum TLR2 and TLR4 in patients with Hashimoto&#x2019;s thyroiditis. Endocr Metab Immune Disord Drug Targets. 2020;20:118&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">30924423</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwahab SF, Hamdy S, Osman AM, et al. . Association of the polymorphism of the Toll-like receptor (TLR)-3 and TLR-9 genes with hepatitis C virus-specific cell-mediated immunity outcomes among Egyptian health-care workers. Clin Exp Immunol. 2021;203:3&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744502</ArticleId><ArticleId IdType="pubmed">32939755</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Liu Y, Tang SJ. Progress of research on toll-like receptors family gene polymorphism and susceptibility to tuberculosis. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:1130&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">30180442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Liu Y, Liu Y, et al. . The association between TLR3 rs3775290 polymorphism and sporadic Parkinson&#x2019;s disease in Chinese Han population. Neurosci Lett. 2020;728:135005.</Citation><ArticleIdList><ArticleId IdType="pubmed">32335220</ArticleId></ArticleIdList></Reference><Reference><Citation>Trust OHNF. Library Services Critical Appraisal Tools | Library Service.
Available at https://www.oxfordhealth.nhs.uk/library/services/training-services/teach-guides-tutorials/critical-appraisal-skills-programme/. [access date November 4, 2021].</Citation></Reference><Reference><Citation>He H, Liu S, Liu P-P, et al. . Association of Toll-like receptor 3 gene polymorphism with the severity of enterovirus 71 infection in Chinese children. Arch Virol. 2017;162:1717&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">28190199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G-P, Xiang K, Sun L, et al. . TLR3 polymorphisms are associated with the severity of hand, foot, and mouth disease caused by enterovirus A71 in a Chinese children population. J Med Virol. 2021:93:6172&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">34061379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A, He H, Lv F, Liu P, Hu J, Chen Z. Association of TLR3-1377C/T gene polymorphisms and expression with susceptibility to enterovirus 71 encephalitis in children. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:39&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390130</ArticleId><ArticleId IdType="pubmed">28100320</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y, Hu P, Zhang J. Relationships between polymorphisms of TLR3 and TLR4 and severity and susceptibility of hand-foot-and-mouth disease infected by EV71. Bing Du Xue Bao. 2019;35:900&#x2013;6.</Citation></Reference><Reference><Citation>Li Y, Zhai S, Li M, et al. . Polymorphisms of TLR7 rs3853839 and rs179010 are associated with susceptibility to and severity of hand, foot and mouth disease caused by enterovirus 71 in male children. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017;33:953&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28712404</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu L, Zhang J, et al. . The association between toll-like receptor 7 single nucleotide polymorphisms and severity of hand, foot and mouth disease caused by enterovirus 71 infection. Zhonghua Chuan Ran Bing Za Zhi. 2017;35:39&#x2013;43.</Citation></Reference><Reference><Citation>Han Y, Mi J, Liu C, et al. . Study on TLR7 expression, interferon-alpha, IL-6 levels and single nucleotide polymorphism of TLR7 gene in children with hand-foot-mouth disease infected by enterovirus 71. Zhonghua Yi Yuan Gan Ran Xue Za Zhi. 2020;30:2721&#x2013;5.</Citation></Reference><Reference><Citation>Deeba E, Koptides D, Lambrianides A, et al. . Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients. Mult Scler Relat Disord. 2019;33:100&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">31177052</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Gao H, Liu Y, et al. . Genetic variants in the regulation region of TLR4 reduce the gastric cancer susceptibility. Gene. 2021;767:145181.</Citation><ArticleIdList><ArticleId IdType="pubmed">33007372</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Ge M, Chen J, et al. . HRS plays an important role for TLR7 signaling to orchestrate inflammation and innate immunity upon EV71 infection. PLoS Pathog. 2017;13:e1006585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5595348</ArticleId><ArticleId IdType="pubmed">28854257</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">20404851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Cao B, Ke C, et al. . IFITM3, TLR3, and CD55 gene SNPs and cumulative genetic risks for severe outcomes in Chinese patients with H7N9/H1N1pdm09 influenza. J Infect Dis. 2017;216:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107409</ArticleId><ArticleId IdType="pubmed">28510725</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan L, Zhou P, Chen A-X, et al. . Toll-like receptor 3 -926T&gt;A increased the risk of breast cancer through decreased transcriptional activity. Oncoimmunology. 2019;8:e1673126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6844318</ArticleId><ArticleId IdType="pubmed">31741776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou P, Fan L, Yu K-D, et al. . Toll-like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity. FASEB J. 2011;25:3489&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">21712495</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng P-L, Song L-X, An H, et al. . Toll-like receptor 3 is associated with the risk of HCV infection and HBV-related diseases. Medicine (Baltim). 2016;95:e2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4902332</ArticleId><ArticleId IdType="pubmed">27227908</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong Y, Song H, You S, et al. . Association of toll-like receptor 3 polymorphisms with chronic hepatitis B and hepatitis B-related acute-on-chronic liver failure. Inflammation. 2013;36:413&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23076446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhang N, Liu L, et al. . Polymorphisms of toll-like receptors 2 and 9 and severity and prognosis of bacterial meningitis in Chinese children. Sci Rep. 2017;7:42796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5311876</ArticleId><ArticleId IdType="pubmed">28202935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J, Hu Z, Dong J, et al. . Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese. Int J Cancer. 2012;130:671&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21412764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Zhu J, Su B, et al. . Effects of TLR7 polymorphisms on the susceptibility and progression of HIV-1 infection in Chinese MSM population. Front Immunol. 2020;11:589010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7649213</ArticleId><ArticleId IdType="pubmed">33193416</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Zhang T, Cao L, et al. . Toll like receptor7 polymorphisms in relation to disease susceptibility and progression in Chinese patients with chronic HBV infection. Sci Rep. 2017;7:12417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5622102</ArticleId><ArticleId IdType="pubmed">28963470</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan L, Hou P, Kang X, Shang Y. Effects of single-nucleotide polymorphisms in the TLR7 and TLR9 genes of asthmatic children. Ann Clin Lab Sci. 2018;48:601&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30373864</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen N, Fu Q, Deng Y, et al. . Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA. 2010;107:15838&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2936646</ArticleId><ArticleId IdType="pubmed">20733074</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Gao H, Li A, et al. . Impact of genetic variation in 3&#x2019;UTR on NSCLC genetic susceptibility. J Oncol. 2020;2020:7593143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7171665</ArticleId><ArticleId IdType="pubmed">32351566</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S, Liu J, Zhang Y, et al. . Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility. Int J Clin Exp Pathol. 2014;7:8118&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4270586</ArticleId><ArticleId IdType="pubmed">25550860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi X, Liu J, Zhang L, et al. . Relationship between TLR3 polymorphisms and disease progression in patients with chronic HCV infection combined with HIV infection. Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi. 2017;25:965&#x2013;9.</Citation></Reference><Reference><Citation>Mosaad YM, Metwally SS, Farag RE, et al. . Association between toll-like receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and chronic HCV. Immunol Invest. 2019;48:321&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30321082</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>